• Home
  • Victims
    • Vaccine Victims Memorial
    • Gardasil & Silgard
      • G / S Australasia
        • G / S Australia
        • G / S New Zealand
      • G / S Europe
        • G / S Czech Republic
        • G / S Denmark
        • G / S France
        • G / S Germany
        • G / S Ireland
        • G / S Italy
        • G / S Norway
        • G / S Scotland
        • G / S Spain
        • G / S United Kingdom
      • G / S N. America
        • G / S Canada
        • G / S Mexico
        • G / S United States
      • G / S S. America
        • G / S Brazil
        • G/S Colombia
    • Cervarix
      • Cervarix Asia
        • Cervarix India
        • Cervarix Philippines
      • Cervarix Europe
        • Cervarix Czech
        • Cervarix Netherlands
        • Cervarix Scotland
        • Cervarix Slovakia
        • Cervarix Spain
        • Cervarix UK
      • Cervarix N. America
        • Cervarix Mexico
  • Resources
    • HPV Testing Resources
      • Pre-HPV Vaccination
      • Post-HPV Vaccination
    • Medical Professionals
    • Vaccine Injury Attorneys
    • Political Action Groups
    • Vaccine Groups
    • Vaccine Victims Hotline
  • SANE Vax Press Releases
  • Videos
    • Vaccine Safety Videos
    • Vaccine Victim Videos
    • Pharma Videos
  • About
    • About Us
    • Who We Are
    • Press Releases
    • SANE Vax in the News
    • Contact Us

SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

  • NEWS
    • Government Agencies
      • African
      • Asian
      • Australasian
      • European
      • North American
      • South American
      • United Nations
      • WHO
    • Pharmaceutical Companies
      • CSL Biotherapies
      • GlaxoSmithKline
      • Inovio Pharmaceuticals
      • Liquidia Technologies
      • Merck & Co.
      • Novartis
      • Pfizer
      • Qiagen
      • Sanofi Aventis
      • Sanofi Pasteur MSD spmsd
      • Wyeth Laboratories
    • Science & Medicine
      • Cancer
      • Clinical Trials
      • Environmental Health
      • Heavy Metal Toxicity
      • HPV Science
      • Influenza
      • Meningitis
      • Pertussis
      • Pharmaceuticals
      • Rotavirus
      • STD’s
      • Vaccine Science
      • Women’s Health
    • Vaccine Adverse Events
    • Vaccine Injury Reporting
      • VAERS
      • VAMPSS
    • Vaccine Litigation
    • Vaccine Marketing
    • Vaccine Politics/People
    • Vaccine Victims
      • Cervarix Injuries
      • DTP/DTaP Injuries
      • Fluvax Injuries
      • Fluzone Injuries
      • Gardasil / Silgard Injuries
      • Menomune Injuries
      • MMR Injuries
      • Polio Vaccine Injuries
      • Synflorix Injuries
      • Yellow Fever Vaccine
    • Vaccines
      • Anthrax
      • Breast Cancer
      • Chicken Pox
      • Cholera
      • Combination Vaccines
      • Diphtheria
      • Hepatitis B
      • HPV
      • Influenza Vaccines
      • Malaria
      • Measles
      • Meningitis Vaccines
      • MRSA
      • Mumps
      • Norovirus
      • Pertussis Vaccines
      • Pneumococcal Disease
      • Polio
      • Rotavirus Vaccines
      • Shingles
      • Smallpox
      • TB
      • Tetanus
      • Typhoid
      • Yellow Fever Vaccine
    • Vaccines and the Media
  • WORLD NEWS
    • Africa
    • Asia
    • Australasia
    • Europe
    • North America
    • South America
  • RESEARCH
    • Cancer Research
    • Cervarix Vaccine
    • Gardasil/Silgard Vaccine
    • Human Pap. Research
    • Immunization Practices
    • Neurology
    • Vaccine Adjuvants
    • Vac. Ingredient Research
    • Vaccine Injuries
    • Vaccine Preservatives
    • Vaccine Related Research
    • Vaccine Safety
  • CITIZENS SPEAK
    • Cervical Cancer Debate
    • HPV Vax
      • Australian Concerns
      • Canadian Concerns
      • Irish Concerns
      • Spain Concerns
      • UK Concerns
      • United States Concerns
You are here: Home / NEWS . . . . . . . . / Vaccines / HPV / Spanish Press Neglects to Print Gardasil News

Spanish Press Neglects to Print Gardasil News

April 12, 2011 By admin Leave a Comment

[Note from SaneVax:  On 10 April 2011, the AAVP in Spain sent the following press release to their local newspaper. The SaneVax Team just got word today that the editor(s) obviously didn’t think the article was news-worthy and neglected to publish it. We disagree, particularly since medical authorities are using Gardasil® for older women, regardless of the most recent FDA decision not to expand its use to include women over the age of 26. Therefore, a rough English translation of the entire article appears below. Hopefully, the people of Spain can get the news here.]

The FDA has rejected the use of Gardasil for women 27 to 45 years following the request from Merck to the FDA for expanded use of Gardasil in adult population.

From AAVP (Association of Concerned by Papillomavirus Vaccine) believe that this decision is a victory for consumers around the world.

A press conference conducted by Merck on April 6, 2011 indicates that the FDA has said not enough evidence to prove that Gardasil prevents cervical cancer related to HPV in women older than 27 years.

Similarly, AAVP believes that Gardasil has not yet demonstrated its efficacy in preventing cervical cancer in women under 26 years, since they do not know the real effectiveness before 30-35 years, since cancer is intended prevent it takes 30 or more years to develop, and trials have been conducted have only been six years (phase II) and three years (phase III). Therefore, given the brevity of the tests would have to wait many years to compare the development of breast cancer in women who have been vaccinated and those who do not have. We believe that in Spain, where the incidence of this disease is very low, wait should have been more prudent.

 To all this, join the notification of adverse events that are occurring worldwide. In VAERS (American System of Adverse Reactions to Vaccines) and has been reported 93 deaths and 21,292 adverse reaction reports. This fact is very significant especially if we consider that only 10% of reported cases.

AAVP asked the Spanish Agency of Medicines and Health Products (Competent Authority) a list of adverse effects on our country. Until September 15, 2009 are recorded 508 reports of suspected adverse reactions associated with vaccines against HPV, without knowing which is the data today.

What worries us is that in Europe and specifically in Spain has expanded the use of Gardasil for women up to age 45, when there are studies that confirm the drug itself, which in the case of a woman is infected by some of the virus in the vaccine, there is an increase of 44.6% in the risk of cervical cancer.

AAVP calls on the Spanish health authorities to suspend the extension of vaccination to 45 years early. It also requests the withdrawal of the vaccine market, while not an independent study on its safety and effectiveness of not doing so will risky “reckless” the health of women and the Health of this country.

Learn more at http://www.aavp.es

Related

Filed Under: HPV, Spain Tagged With: HPV vaccine, immunization

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Follow Us

SaneVax on FacebookSaneVax on TwitterSaneVax on LinkedInSaneVax on YoutubeSaneVax RSS Feed

Help Support SaneVax

Notice: We need your support. This massive research & presentation comes from a team of volunteers. We need your help to keep this critical information available.



SaneVax relies on support from participants like you. We are a 501 (c)(3) non-profit corporation, donations are tax deductible. Help keep this venue available and support the spirit – Thank you!

This Week’s Survivor

Brittany from Ohio

Categories

Links

  • Creating an HPV Industry
  • File a VAERS Report
  • Gardasil and Unexplained Deaths
  • HPV Industry Timeline
  • HPV Mechanisms of Action in Women
  • HPV Vaccine Fact Sheet
  • Petition: Rescind HPV Vaccine Approval
  • Presentation to the FDA
  • Supreme Court Arguments

HPV Vaccine VAERS Reports

Description 12/14/2019  TOTAL
Disabled 3,092
Deaths 523
Did Not Recover 13,072
Abnormal Smear 695
Cervical Cancer 186
Infertility 52
Life-threatening 1,001
Emergency Room 15,419
Hospitalized 6,448
Extended Hosp. Stay 304
Serious 9,497
Total Adverse Events 64,270

Access expanded report here.

Related

Subscribe2


 

Log In

Featured Video

Is 'protecting' against 4 types of HPV enough to warrant the risks?

HPV vaccine documentary Japan. Gardasil and Cervarix

News

SaneVax News Blog!
News

Videos

Safety • Victims • Pharma
No Genetic Epidemic

Contact

Contact S.A.N.E.Vax
S.A.N.E.VAX log thumbnail

Copyright © 2023 SaneVax, Inc. · Site by TheWebElves.com a div. of KalaRhythms.org · Log in